APRIL and BAFF: Novel Biomarkers for Central Nervous System Lymphoma

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0796-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Primary Central Nervous System Lymphoma

Contemporary Neurosurgery
2010English

Primary Central Nervous System Lymphoma

Journal of Neurosurgery
SurgeryNeurology
1985English

The Process of Somatic Hypermutation Increases Polyreactivity for Central Nervous System Antigens in Primary Central Nervous System Lymphoma.

Haematologica
Hematology
2020English

Primary Central Nervous System Lymphoma: A Curable Disease

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Neurolymphomatosis Appeared Following Primary Central Nervous System Lymphoma

Internal Medicine
Internal MedicineMedicine
2017English

Primary Central Nervous System Lymphoma: Coming or Going?

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Salvage Therapy for Refractory Aids-Related Primary Central Nervous System Lymphoma

Case Reports in Oncological Medicine
Oncology
2012English

Central Nervous System Hodgkin Lymphoma Developing During Systemic Chemotherapy

British Journal of Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy